Medicx Share Discussion Threads

[redips2] 25/5/2016 11:29

OK...2525 taken .

[redips2] 25/5/2016 08:55

Maybe time to take some more .

[skinny] 24/5/2016 09:09

Financial results
· 0.4 pence per share increase in EPRA NAV for the period to 31 March 2016 to 71.2 pence per share (30 September 2015: 70.8 pence per share)
· Quarterly dividend of 1.4875p per share announced in April 20164; total dividends of 5.95p per share expected for the year or 6.8% dividend yield, an increase of 0.8% (2015: total dividends of 5.9p per share; 7.0% dividend yield)4,7
· EPRA earnings of £6.8 million, equivalent to 1.8p per share (31 March 2015: £7.0 million; 2.0p per share)8
· Dividend and underlying dividend cover of 63% and 71% for the six month period (31 March 2015: 67% and 67%)9
· EPRA NNNAV of £226.3 million equivalent to 60.3p per share (30 September 2015: 228.9 million; 62.7p per share)8

Investments
· New committed investments between 1 October 2015 and 31 March 2016 of £27.4 million
· £573.0 million committed investment in 151 primary healthcare properties, an increase of 2.4% over the period (4 December 2015: £559.5 million, 148 properties)1,10
· Annualised rent roll now £36.7 million with 87% of rents reimbursed by the NHS, an increase of £0.9 million, or 2.5%, since 4 December 20151
· Strong pipeline of approximately £144.0 million of further acquisition opportunities1

Funding
· Market capitalisation £328.5 million1 including £8.5 million net proceeds raised from 10.0 million shares issued since 1 October 2015 at an average issue price of 85.0p per share
· Total drawn debt facilities at 31 March 2016 of £337.4 million with an average all-in fixed rate of debt of 4.45% and an average unexpired term of 14.5 years, close to the average unexpired lease term of the investment properties of 15.7 years and compared with 4.45% and 15.0 years at 30 September 2015
· Net debt of £311.6 million equating to 52.3% adjusted gearing at 31 March 2016 (30 September 2015: £281.4 million; 50.2%)

[ih_552354] 21/4/2016 09:29

Could be pi's diversifying and taking a 7% yield...+ a little share price increase per annum gives a nice return. V good for an ISA.

[skinny] 20/4/2016 16:12

3+year high @89p

[pooroldboy55] 20/4/2016 13:18

So whats going on today ?

[losos] 14/4/2016 11:58

ih_552354 & redips2 -"keen to get some in the ISA new year"

Have just put my ISA allowance in for this year, waiting now to see how this goes. It often pays to wait after an IC tip as the MM's know what's in the mag and 'adjust' their prices accordingly.

[redips2] 01/4/2016 10:11

Me too.....exactly the same thoughts .

[ih_552354] 01/4/2016 08:58

I do wish IC would stop tipping this - keen to get some in the ISA new year as low as possible.

[redips2] 24/2/2016 09:35

Happy/lucky..... to have nabbed some when they gapped down.....all good .

[nimbo1] 24/2/2016 08:22

The strength has also surprised me so soon after ex div date - perhaps someone after some diversification and relatively 'secure' income.

[badtime] 23/2/2016 18:30

This has looked sprightly exdiv

[eeza] 10/2/2016 07:57

new primary healthcare medical centre in Brynhyfryd, Swansea.

[badtime] 08/2/2016 21:46

Looks okay...can't c anything about divi cover which has been improving

[eeza] 08/2/2016 21:09

NAV & Trading update timed at 1730.

[speedsgh] 02/2/2016 09:54

Yes, looks like 5.95p to be paid out in current FY (4 x 1.4875p).

[eeza] 02/2/2016 08:08

Div notice

XD 18 Feb
Pay 31 Mar - 1.4875p
Expect 5.95p for year to end of Sept 2016

[badtime] 29/1/2016 14:03

Thought we might get notification of dividend today

[bodlan] 18/1/2016 13:09

Looks like there is an MXF on the NYSE. The Mexico Fund Inc. Somehow their holdings are being shown on the HL website under the UK MXF? Just sent an email to HL to get them to check it out.

[bodlan] 18/1/2016 12:52

Just looking at MXF for the first time and assumed that their main area of investment was the UK. However when looking at their holdings on the Hargreaves website it looks like mainly Mexico?? Their own website does not mention Mexico. Are their more than one MXF's.

[rathkum] 10/12/2015 10:23

Appreciate your post ezza.

[badtime] 10/12/2015 09:34

Thanks for that EEza...would explain today's rise....happy collecting the div personally

[eeza] 10/12/2015 08:57

Tipped in Telegraph


Questor share tip: MedicX offers 7pc dividend income from infrastructure
The fund invests in a portfolio of GP surgeries across the country that generate healthy dividends from rental income, says Questor

By John Ficenec, Questor Editor - 5:40PM GMT 09 Dec 2015
MedicX
84.75p -0.25p
Questor says BUY

MedicX [LON:MXF], the infrastructure fund that owns GP surgeries across the UK and Ireland, delivered a solid set of annual results yesterday, with the 7pc dividend looking increasingly attractive.

Prior to the formation of the National Health Service in 1948, surgeries largely lacked the facilities their patients needed. Nowadays, GP surgeries are used as the front line of the health service, and only modern, purpose-built facilities will do.

MedicX raises the finance for these structures to be built. The company then owns the buildings for their lifetime and earns rent for their use. These rental payments are almost entirely backed by the Government due to the essential role of GP surgeries in the health care system.

The debt MedicX uses to finance its portfolio is agreed for 15 years and fixed at a low interest rate of 4.45pc, on average.

The company’s investment portfolio increased by 8pc to £559m in the year to the end of September. The rent charged on those buildings rose 9.1pc to £35.8m. MedicX has a conservative 50pc loan-to-value ratio, with net debts of £281m at the end of September.

The value of the investment portfolio, minus the debt, gives a net asset value of £258m, or 70.8p per share, at the end of September. MedicX steadily returns cash to investors through quarterly dividend payments, which total 5.9p for the year, or a prospective yield of 7pc given the current 84.25p share price.

The shares trade at a 20pc premium to the net asset value but that looks warranted given the steady income and opportunity for growth. Buy.